{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06425055",
            "orgStudyIdInfo": {
                "id": "EYP001-208"
            },
            "organization": {
                "fullName": "Enyo Pharma",
                "class": "INDUSTRY"
            },
            "briefTitle": "Vonafexor ALPort Syndrome Efficacy & Safety TRIAl-1 (ALPESTRIA-1)",
            "officialTitle": "Vonafexor Fixed Dose-escalation Safety and Proof-of-concept Study in Patients With at Risk of Progression Alport Syndrome",
            "acronym": "ALPESTRIA-1",
            "therapeuticArea": [
                "Rare Diseases"
            ],
            "study": "vonafexor-alport-syndrome-efficacy-safety-trial-alpestria"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "startDateStruct": {
                "date": "2024-07-31",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-07-21",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-10-13",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-05-14",
            "studyFirstSubmitQcDate": "2024-05-17",
            "studyFirstPostDateStruct": {
                "date": "2024-05-22",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-29",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-30",
                "type": "ESTIMATED"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Enyo Pharma",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study is a proof-of-concept trial of vonafexor safety, its effects on kidney function in subjects with at risk of progression Alport syndrome.",
            "detailedDescription": "This is a multicenter study and several clinical sites and countries will be involved.\n\nThis single arm, fixed dose escalation, open-label, non-randomized study will evaluate three dose levels of vonafexor on safety, tolerability and their effect on kidney function and renal biomarkers in 20 patients with AS at risk of progression.\n\nThe total duration of study for a participant will be up to 40 weeks and include a screening period, a treatment period of 24 weeks and a follow-up period of 12 weeks."
        },
        "conditionsModule": {
            "conditions": [
                "Alport Syndrome"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "Single arm fixed dose escalation",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Single arm fixed dose escalation",
                    "type": "EXPERIMENTAL",
                    "description": "This is a single arm fixed dose escalation with three dose levels of vonafexor, all QD.",
                    "interventionNames": [
                        "Drug: Vonafexor"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Vonafexor",
                    "description": "* One tablet of a low dose of vonafexor QD from Day 1 to Week 4\n* One tablet of a medium dose of vonafexor QD from Week 5 to Week 8\n* One tablet of a high dose of vonafexor QD from Week 9 to Week 24",
                    "armGroupLabels": [
                        "Single arm fixed dose escalation"
                    ],
                    "otherNames": [
                        "EYP001a"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of Treatment-Emergent Adverse Event (TEAE)",
                    "description": "To assess the safety and tolerability of vonafexor",
                    "timeFrame": "From first dose of treatment until 2 weeks after last dose of treatment, i.e assessed up to 26 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in eGFR",
                    "description": "To determine the on with the off-treatment effect of three dose levels of vonafexor on renal function",
                    "timeFrame": "During on-treatment (assessed up to 24 weeks) and off-treatment periods (assessed up to 36 weeks) compared to baseline"
                },
                {
                    "measure": "Vonafexor plasma concentrations",
                    "description": "To determine vonafexor plasma concentrations levels",
                    "timeFrame": "During on-treatment period, assessed up to 24 weeks"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Change in albuminuria",
                    "description": "To determine the effect of vonafexor on and off treatment on exploratory renal biomarkers",
                    "timeFrame": "During on-treatment (assessed up to 24 weeks) and off-treatment periods (assessed up to 36 weeks) compared to baseline"
                },
                {
                    "measure": "Change in proteinuria",
                    "description": "To determine the effect of vonafexor on and off treatment on exploratory renal biomarkers",
                    "timeFrame": "During on-treatment (assessed up to 24 weeks) and off-treatment periods (assessed up to 36 weeks) compared to baseline"
                },
                {
                    "measure": "Change in Neutrophil Gelatinase Associated Lipocalin (NGAL)",
                    "description": "To determine the effect of vonafexor on and off treatment on exploratory renal biomarkers",
                    "timeFrame": "During on-treatment (assessed up to 24 weeks) and off-treatment periods (assessed up to 36 weeks) compared to baseline"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Signed informed consent (also for legal representatives, as applicable in the US for under eighteen patients).\n* Has confirmed diagnosis of Alport syndrome: clinical diagnosis (haematuria, family history, hearing loss, ocular change) OR a kidney biopsy showing glomerular basement membrane abnormalities consistent with AS, AND Genetic confirmation of AS.\n* Has eGFR between \u2265 30 and \\< 90 ml/min/1.73m2.\n* Has increased albuminuria criteria i.e. UACR \u2265 300 mg/g.\n* If on an angiotensin converting enzyme inhibitor (ACEi) and/or angiotensin receptor blocker (ARB), should be on a stable well tolerated treatment during at least the 60 days prior D1.\n* If on Sodium-Glucose Transport Protein 2 (SGLT2), should be on stable well tolerated treatment with SGLT2 during at least 60 days prior D1.\n* If patient has a history of arterial hypertension, should be on stable anti-hypertensive therapy for at least 60 days prior to D1 and deemed controlled by the investigator at screening and D1.\n* Sexually active female subjects of childbearing potential and sexually mature male subjects must use two acceptable effective methods of contraception for the entire duration of the study and for at least 6 weeks after last dose.\n* Has negative results for hepatitis B surface antigen (HBsAg), hepatitis C virus (HCV) antibody, and human immunodeficiency virus (HIV).\n* Is able to understand all study procedures in the informed consent form (ICF) and willing to comply with all aspects of the protocol.\n\nExclusion Criteria:\n\n* Is an employee of a site, clinical research organization, vendor, or sponsor involved with this study.\n* Is pregnant or breastfeeding.\n* Has participated in any investigational drug study within 60 days prior to D1.\n* Any clinically significant illness within 30 days before D1 or surgical or medical condition (other than Alport syndrome) that could interfere with the subject's study compliance; confound the study results; impact subject safety.\n* Any history of active malignancy within the last 1 year before D1.\n* Any other condition or circumstance that, in the opinion of the investigator, may make the subject unlikely to complete the study or comply with study procedures and requirements, or may pose a risk to the subject's safety and well-being.\n* Has a history of an allergic condition that required the prescription of an emergency epinephrine injection (such as the EpiPen\u00ae Auto-Injector).\n* Any prohibited co-medications within 30 days prior D1.\n* Has ALT or AST above near normal (\\>1.5\u00d7ULN) at baseline.\n* Are at high risk for atherosclerotic cardiovascular disease (ASCVD) risk, with an LDL-C level \\> 160 mg/dL (4.15 mmol/L) and subjects at intermediate risk for ASCVD risk, with a LDL-C level \\> 190 mg/dL (4.91 mmol/L).\n* Has moderate or severe hepatic impairment (Child-Pugh score B or C).\n* Is taking CYP3A4/5 inhibitors or inducers.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "16 Years",
            "maximumAge": "55 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Isabelle Martin",
                    "role": "CONTACT",
                    "phone": "+33 4 37 70 02 44",
                    "email": "clinicaltrial@enyopharma.com"
                }
            ],
            "locations": [
                {
                    "facility": "Dr Eric Wallace - University of Alabama",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Birmingham",
                    "state": "Alabama",
                    "zip": "35294",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Christina Desruisseau",
                            "role": "CONTACT",
                            "email": "csingleton@uabmc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.52066,
                        "lon": -86.80249
                    }
                },
                {
                    "facility": "Dr Anjay Rastogi - UCLA Health, David Geffen School of Medicine",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Gabriel Munoz",
                            "role": "CONTACT",
                            "email": "GabrielMunoz@mednet.ucla.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Dr Arnold Silva - Boise Kidney & Hypertension",
                    "status": "RECRUITING",
                    "city": "Boise",
                    "state": "Idaho",
                    "zip": "83703",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Samantha Stinemetz",
                            "role": "CONTACT",
                            "email": "samantha@cardiorenalinstitute.com"
                        },
                        {
                            "name": "Victor Capetillo",
                            "role": "CONTACT",
                            "email": "victor@injurycareresearch.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.6135,
                        "lon": -116.20345
                    }
                },
                {
                    "facility": "Dr Suneel Udani - NANI Research",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Hinsdale",
                    "state": "Illinois",
                    "zip": "60521",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kelly Johnston",
                            "role": "CONTACT",
                            "email": "KJohnston@nephdocs.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.80086,
                        "lon": -87.93701
                    }
                },
                {
                    "facility": "Dr Tingting Li - Washington University",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63110",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Michelle Bloom",
                            "role": "CONTACT",
                            "email": "mbloom@wustl.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "Dr Andrew Bomback - Columbia University Medical Center",
                    "status": "NOT_YET_RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "60521",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Brianna Ortiz",
                            "role": "CONTACT",
                            "email": "bo2323@cumc.columbia.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Dr James Simon - Cleveland Clinic Foundation",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44195",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jennifer Czerr",
                            "role": "CONTACT",
                            "email": "Czerrj@ccf.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                },
                {
                    "facility": "Dr Ankit Mehta - Renal Disease Research Institute",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75126",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lauren Rogers",
                            "role": "CONTACT",
                            "email": "Rogersl@dneph.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Pr Claire Rigothier - CHU De Bordeaux",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Bordeaux",
                    "zip": "33076",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "ENYO Pharma",
                            "role": "CONTACT",
                            "email": "clinicaltrial@enyopharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.84044,
                        "lon": -0.5805
                    }
                },
                {
                    "facility": "Dr Thomas Robert - H\u00f4pital de la Conception",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Marseille",
                    "zip": "13385",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "ENYO Pharma",
                            "role": "CONTACT",
                            "email": "clinicaltrial@enyopharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.29551,
                        "lon": 5.38958
                    }
                },
                {
                    "facility": "Dr Moglie Le Quintrec - Hopital Lapeyronie",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Montpellier",
                    "zip": "34090",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "ENYO Pharma",
                            "role": "CONTACT",
                            "email": "clinicaltrial@enyopharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.61092,
                        "lon": 3.87723
                    }
                },
                {
                    "facility": "Pr. Bertrand Knebelmann - Necker Enfants Malades",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Paris",
                    "zip": "75015",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "ENYO Pharma",
                            "role": "CONTACT",
                            "email": "clinicaltrial@enyopharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "Charite Universitatsmedizin Berlin",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Berlin",
                    "zip": "10117",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "ENYO Pharma",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.52437,
                        "lon": 13.41053
                    }
                },
                {
                    "facility": "University Medicine Goettingen",
                    "status": "NOT_YET_RECRUITING",
                    "city": "G\u00f6ttingen",
                    "zip": "37075",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "ENYO Pharma",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.53443,
                        "lon": 9.93228
                    }
                },
                {
                    "facility": "Fundacio Puigvert",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Barcelona",
                    "zip": "08025",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "ENYO Pharma",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Hospital Virgen de la Arrixaca",
                    "status": "NOT_YET_RECRUITING",
                    "city": "El Palmar",
                    "zip": "30120",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "ENYO Pharma",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.93939,
                        "lon": -1.16095
                    }
                },
                {
                    "facility": "Fundacion Jimenez Diaz",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Madrid",
                    "zip": "28040",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "ENYO Pharma",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital De Sagunto",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Sagunto",
                    "zip": "46520",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "ENYO Pharma",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.68333,
                        "lon": -0.26667
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Individual participant data that underline published results might be shared upon request with researchers who provide a methodologically sound proposal and to achieve objectives as set in the approved proposal.\n\nIPD will be shared deidentified and from 3 months and ending 5 years following article publication.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP"
            ],
            "timeFrame": "From 3 months and ending 5 years following article publication."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009394",
                    "term": "Nephritis, Hereditary"
                },
                {
                    "id": "D000013577",
                    "term": "Syndrome"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004194",
                    "term": "Disease"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000014564",
                    "term": "Urogenital Abnormalities"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000009393",
                    "term": "Nephritis"
                },
                {
                    "id": "D000007674",
                    "term": "Kidney Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000000013",
                    "term": "Congenital Abnormalities"
                },
                {
                    "id": "D000003095",
                    "term": "Collagen Diseases"
                },
                {
                    "id": "D000003240",
                    "term": "Connective Tissue Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "asFound": "Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20559",
                    "name": "Disease Progression",
                    "relevance": "LOW"
                },
                {
                    "id": "M12338",
                    "name": "Nephritis",
                    "relevance": "LOW"
                },
                {
                    "id": "M12339",
                    "name": "Nephritis, Hereditary",
                    "asFound": "Alport Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12",
                    "name": "Congenital Abnormalities",
                    "relevance": "LOW"
                },
                {
                    "id": "M17314",
                    "name": "Urogenital Abnormalities",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M10698",
                    "name": "Kidney Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15045",
                    "name": "Rheumatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6323",
                    "name": "Collagen Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6464",
                    "name": "Connective Tissue Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T303",
                    "name": "Alport Syndrome",
                    "asFound": "Alport Syndrome",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC05",
                    "name": "Musculoskeletal Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}